Araujo et al. recently reported that OSM derived from tumor-infiltrating myeloid cells reprograms fibroblasts to secrete VEGF and the chemokines CXCL1 and CXCL16, resulting in enhanced myeloid cell recruitment and breast cancer progression (34). Here, CXCL1 is linked to neoplasm.